FDA OKs Syntermed's latest version of NeuroQ software

05/30/2013 | AuntMinnie.com (free registration)

Syntermed has received FDA 510(k) clearance for upgraded NeuroQ nuclear medicine software, which can be used to evaluate amyloid accumulation in the brain. The software is designed to assess the distribution of imaging agents in PET images and can compare two images from the same patient.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC